Please try another search
PT Merck Tbk manufactures and sells pharmaceutical products in Indonesia. The company operates through three segments: Biopharma, Consumer Health, and Others. It offers health care products in the areas of cardiovascular, metabolic, oncology, endocrinology, fertility, and neurodegenerative diseases, as well as general medicines. The company also engages in discovering, developing, manufacturing, and marketing pharmaceutical and biological prescription medicines to treat colorectal cancer, head and neck cancer, multiple sclerosis, infertility, growth hormone disorders, and diabetes, as well as thyroid disorders comprising hyperthyroidism and hypothyroidism. In addition, it is involved in the office/property leasing and management activities. The company was formerly known as PT Merck Indonesia Tbk and changed its name to PT Merck Tbk in June 2002. The company was founded in 1970 and is headquartered in Jakarta Timur, Indonesia. PT Merck Tbk operates as a subsidiary of Merck Holding GmbH.
Name | Age | Since | Title |
---|---|---|---|
Bambang Nurcahyo | 51 | 2009 | Finance Director & Director |
Parulian Simanjuntak | 77 | 2003 | Independent Commissioner |
Mei Lin Tang | 58 | 2017 | President Commissioner |
Evie Yulin | 56 | 2011 | President Director & Biopharma Director |
Arryo Aritrixso Teguh Putranto Wachjuwidajat | 51 | 2015 | Plant Director & Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review